(1)
Efficacy and Safety of Tralokinumab With Concomitant Topical Corticosteroids in North American Adults With Moderate-to-Severe Atopic Dermatitis: A Subanalysis of the ECZTRA 3 Trial. J of Skin 2020, 4 (6), s97. https://doi.org/10.25251/skin.4.supp.97.